[1] |
Nakagawa S, Yamashiro K, Tsujikawa A, et al. The time course changes of choroidal neovascularization in angioid streaks[J]. Retina,2013,33(4):825-833.
|
[2] |
Browning AC, Chung AK, Ghanchi F, et al. Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks: one-year results of a prospective case series[J]. Ophthalmology,2005,112(7):1227-1231.
|
[3] |
Arias L, Pujol O, Rubio M, et al. Long-term results of photodynamic therapy for the treatment of choroidal neovascularization secondary to angioid streaks[J]. Graefes Arch Clin Exp Ophthalmol,2006,244(6):753-757.
|
[4] |
Lommatzsch A, Spital G, Trieschmann M, et al. Intraocular application of bevacizumab for the treatment of choroidal neovascularization secondary to angioid streaks[J]. Ophthalmologe, 2007,104(4):325-328.
|
[5] |
Ladas ID, Kotsolis AI, Ladas DS, et al. Intravitreal ranibizumab treatment of macular choroidal neovascularization secondary to angioid streaks: one-year results of a prospective study[J]. Retina-J Ret Vit Dis,2010,30(8):1185-1189.
|
[6] |
Verteporfin Roundtable 2000 and 2001 Participants. Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes[J]. Retina,2002,22(1):6-18.
|
[7] |
张承芬. 眼底病学[M]. 北京:人民卫生出版社,1998:422-423.
|
[8] |
Menchini U, Virgili G, Introini U, et al. Outcome of choroidal neovascularization in angioid streaks after photodynamic therapy[J]. Retina,2004,24(5):763-771.
|
[9] |
Ladas ID, Georgalas I, Rouvas AA, et al. Photodynamic therapy with verteporfin of choroidal neovascularization in angioid streaks: conventional versus early retreatment[J]. Eur J Ophthalmol, 2005,15(1):69-73.
|
[10] |
Jurklies B, Bornfeld N, Schilling H,et al. Photodynamic therapy using verteporfin for choroidal neovascularization associated with angioid streaks—long-term effects[J]. Ophthalmic Res,2006,38(4):209-217.
|
[11] |
Donati MC, Virgili G, Bini A, et al. Intravitreal bevacizumab (Avastin) for choroidal neovascularization in angioid streaks: a case series[J]. Ophthalmologica,2009,223(1):24-27.
|
[12] |
Finger RP, Charbel Issa P, Schmitz-Valckenberg S, et al. Long-term effectiveness of intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks in pseudoxanthoma elasticum[J]. Retina-J Ret Vit Dis,2011,31(7):1268-1278.
|
[13] |
Artunay O, Yuzbasioglu E, Rasier R, et al. Combination treatment with intravitreal injection of ranibizumab and reduced fluence photodynamic therapy for choroidal neovascularization secondary to angioid streaks: preliminary clinical results of 12-month follow-up[J]. Retina,2011,31(7):1279-1286.
|
[14] |
Prabhu VV, Morris RJ, Shah PK, et al. Combination treatment of low fluence photodynamic therapy and intravitreal ranibizumab for choroidal neovascular membrane secondary to angioid streaks in Paget′s disease-12 month results[J]. Indian J Ophthalmol, 2011,59(4):306-308.
|
[15] |
Pece A, Russo G, Ricci F, et al. Verteporfin photodynamic therapy combined with intravitreal triamcinolone for choroidal neovascularization due to angioid streaks[J]. Clin Ophthalmol,2010,4:525-530.
|
[16] |
Gliem M, Finger RP, Fimmers R, et al. Treatment of choroidal neovascularization due to angioid streaks: a comprehensive review[J]. Retina-J Ret Vit Dis,2013,33(7):1300-1314.
|